Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy – a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol

BACKGROUND: Approximately 40% of colorectal cancer patients will develop colorectal liver metastases (CRLM). The most effective approach to increase long-term survival is CRLM complete resection. Unfortunately, only 10–15% of CRLM are initially considered resectable. The objective response rates (OR...

Descripción completa

Detalles Bibliográficos
Autores principales: Boilève, Alice, Maillard, Aline, Wagner, Mathilde, Dromain, Clarisse, Laurent, Christophe, Dupont Bierre, Eric, Le Sourd, Samuel, Audemar, Franck, Ulusakarya, Ayhan, Guerin-Meyer, Veronique, Smisth, Denis, Pezzella, Veronica, De Baere, Thierry, Goere, Diane, Gelli, Maximiliano, Taieb, Julien, Boige, Valérie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990591/
https://www.ncbi.nlm.nih.gov/pubmed/32000724
http://dx.doi.org/10.1186/s12885-020-6571-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990591/
https://www.ncbi.nlm.nih.gov/pubmed/32000724
http://dx.doi.org/10.1186/s12885-020-6571-7

Ejemplares similares